Zepto Life Breakthrough Designation
Jun 05, 2026
OrthAlign FDA Clearance for Lantern ASC System, Zepto Life FDA Breakthrough Designation, Precision Spine Launch, Leica Biosystems AI Expansion, ShiraTronics Trial Milestone & Implantica GERD Cost-Effectiveness Study Drive Major MedTech Innovation Advances
OrthAlign, Inc. Received FDA 510(k) clearance for the Lantern® ASC system On 03 June 2026, OrthAlign, Inc., a developer of handheld orthopedic navigation technologies, announced that it had received FDA 510(k) clearance for its Lantern ASC system, a navigation solution designed to provide the accuracy of advance...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
